Fatih Selçukbırıcık

2.4k total citations
93 papers, 761 citations indexed

About

Fatih Selçukbırıcık is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Fatih Selçukbırıcık has authored 93 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 42 papers in Oncology and 40 papers in Surgery. Recurrent topics in Fatih Selçukbırıcık's work include Gastric Cancer Management and Outcomes (19 papers), Metastasis and carcinoma case studies (16 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Fatih Selçukbırıcık is often cited by papers focused on Gastric Cancer Management and Outcomes (19 papers), Metastasis and carcinoma case studies (16 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Fatih Selçukbırıcık collaborates with scholars based in Türkiye, United States and Germany. Fatih Selçukbırıcık's co-authors include Deniz Tural, Nil Molinas Mandel, Süheyla Serdengeçti, Evin Büyükünal, Ahmet Bılıcı, Sibel Erdamar, Alan A. Sag, Özcan Yıldız, Sergülen Dervişoğlu and Hande Turna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Fatih Selçukbırıcık

83 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatih Selçukbırıcık Türkiye 16 342 247 246 101 94 93 761
Doğan Uncu Türkiye 15 261 0.8× 161 0.7× 348 1.4× 80 0.8× 105 1.1× 96 704
Mesut Şeker Türkiye 17 488 1.4× 410 1.7× 615 2.5× 109 1.1× 152 1.6× 98 1.3k
Shakil H. Merchant United States 16 251 0.7× 193 0.8× 251 1.0× 73 0.7× 218 2.3× 22 805
Mitsuru Sugimoto Japan 16 275 0.8× 365 1.5× 298 1.2× 61 0.6× 23 0.2× 100 722
J.M. Gornet France 11 182 0.5× 284 1.1× 359 1.5× 35 0.3× 89 0.9× 24 801
Hamed Daw United States 18 273 0.8× 205 0.8× 380 1.5× 129 1.3× 179 1.9× 99 954
Ricardo Cubedo Spain 14 637 1.9× 223 0.9× 566 2.3× 131 1.3× 148 1.6× 50 1.1k
Masayuki Tatsuta Japan 13 359 1.0× 333 1.3× 391 1.6× 86 0.9× 60 0.6× 34 867
G.S.C. Chiang Singapore 17 166 0.5× 160 0.6× 147 0.6× 118 1.2× 180 1.9× 41 997
Eunmi Nam South Korea 15 660 1.9× 295 1.2× 513 2.1× 129 1.3× 128 1.4× 30 1.1k

Countries citing papers authored by Fatih Selçukbırıcık

Since Specialization
Citations

This map shows the geographic impact of Fatih Selçukbırıcık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatih Selçukbırıcık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatih Selçukbırıcık more than expected).

Fields of papers citing papers by Fatih Selçukbırıcık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatih Selçukbırıcık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatih Selçukbırıcık. The network helps show where Fatih Selçukbırıcık may publish in the future.

Co-authorship network of co-authors of Fatih Selçukbırıcık

This figure shows the co-authorship network connecting the top 25 collaborators of Fatih Selçukbırıcık. A scholar is included among the top collaborators of Fatih Selçukbırıcık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatih Selçukbırıcık. Fatih Selçukbırıcık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Helvacı, Kaan, et al.. (2025). Endocrine Adverse Events in Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis. Medicina. 61(1). 123–123. 3 indexed citations
2.
3.
4.
Selçukbırıcık, Fatih, et al.. (2025). Late-Onset Myocarditis Following Immune Checkpoint Inhibitors Therapy: A Case Series with Literature Review. Medicina. 61(2). 302–302. 1 indexed citations
5.
6.
7.
Arslan, Çağatay, Fatih Selçukbırıcık, Ömer Fatih Ölmez, et al.. (2024). Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Medicina. 60(12). 2103–2103.
8.
Tural, Deniz, Çağatay Arslan, Fatih Selçukbırıcık, et al.. (2022). Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice. Clinical Genitourinary Cancer. 21(3). 334–341. 2 indexed citations
9.
Seven, Memnun, et al.. (2021). CN6 The effect of the use of a mobile symptom management app during the chemotherapy of breast cancer. Annals of Oncology. 32. S1257–S1258. 1 indexed citations
10.
Tanju, Serhan, et al.. (2018). Level of pleural invasion effects on prognosis in lung cancer. Tumori Journal. 105(2). 155–160. 15 indexed citations
11.
Gümüş, Mahmut, Ahmet Bılıcı, Hatice Odabaş, et al.. (2016). Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors. World Journal of Urology. 35(7). 1103–1110. 8 indexed citations
12.
Sag, Alan A., Fatih Selçukbırıcık, & Nil Molinas Mandel. (2016). Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases. World Journal of Gastroenterology. 22(11). 3127–3127. 29 indexed citations
13.
Selçukbırıcık, Fatih, et al.. (2015). Is Her-2 Status in the Primary Tumor Correlated with Matched Lymph Node Metastases in Patients with Gastric Cancer Undergoing Curative Gastrectomy?. Asian Pacific Journal of Cancer Prevention. 15(24). 10607–10611. 11 indexed citations
14.
Bılıcı, Ahmet & Fatih Selçukbırıcık. (2015). Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy. Tumor Biology. 36(8). 6191–6199. 17 indexed citations
15.
Selçukbırıcık, Fatih, Deniz Tural, Sibel Erdamar, et al.. (2013). Is Helicobacter pylori a Poor Prognostic Factor for HER-2 SISH Positive Gastric Cancer?. Asian Pacific Journal of Cancer Prevention. 14(5). 3319–3322. 1 indexed citations
16.
Tural, Deniz, Mehmet Akif Öztürk, Fatih Selçukbırıcık, et al.. (2013). Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.. PubMed. 18(2). 385–90. 10 indexed citations
17.
Selçukbırıcık, Fatih, et al.. (2013). Signet Cell Carcinoma of Colon in a Nineteen-Year-Old Patient: A Case Report. SHILAP Revista de lepidopterología. 2013. 1–4. 9 indexed citations
18.
Tural, Deniz, Fatih Selçukbırıcık, Fatih Aydoğan, et al.. (2012). Male Breast Cancers Behave Differently in Elderly Patients. Japanese Journal of Clinical Oncology. 43(1). 22–27. 11 indexed citations
19.
Selçukbırıcık, Fatih, et al.. (2011). A Malignant Mass in the Breast Is Not Always Breast Cancer. SHILAP Revista de lepidopterología. 4(3). 521–525. 14 indexed citations
20.
Üstek, Duran, Cumhur Gökhan Ekmekçi, Fatih Selçukbırıcık, et al.. (2006). Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis & Rheumatism. 56(1). 345–350. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doğan Uncu Breakdown of academic impact, for papers by Mesut Şeker Breakdown of academic impact, for papers by Shakil H. Merchant Breakdown of academic impact, for papers by Mitsuru Sugimoto Breakdown of academic impact, for papers by J.M. Gornet Breakdown of academic impact, for papers by Hamed Daw Breakdown of academic impact, for papers by Ricardo Cubedo Breakdown of academic impact, for papers by Masayuki Tatsuta Breakdown of academic impact, for papers by G.S.C. Chiang Breakdown of academic impact, for papers by Eunmi Nam
Rankless by CCL
2026